Here you will find all the research and views on LAURUS LABS that we post on Equitymaster. Use the tools to customize the results to suit your preference!
Here's an analysis of the annual report of LAURUS LABS for 2024-25. It includes a full income statement, balance sheet and cash flow analysis of LAURUS LABS . Also includes updates on the valuation of LAURUS LABS .
Check out LAURUS LABS fact sheet and LAURUS LABS financial results online at Equitymaster.
Check out latest LAURUS LABS Quarterly Results online at Equitymaster.
LAURUS LABS : Get the latest LAURUS LABS Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com.
Discover four Indian pharma CDMO companies investing in capacity expansion, new manufacturing facilities, and advanced technologies to drive long-term growth.
As global drugmakers diversify supply chains beyond China, here are five Indian pharma stocks in focus from the accelerating China+1 strategy.
In this editorial, we look at four Indian pharmaceutical companies with strong CDMO exposure and analyse their business models, financial performance, and order book strength within the growing global pharmaceutical outsourcing theme.
Here are a list of 5 CDMO stocks that you can add to your watchlist as the industry continues to see good growth.
Here are a list of best CDMO in India. Do you own any?
What is the outlook for the stock of Laurus Labs? Find out...
With global manufacturing shifting beyond China, these five stocks are poised to benefit.
These 5 CDMOs are ready to seize the Biosecure Act opportunity.
The Indian pharma industry is expected to double in value by 2030, with strong demand for APIs, formulations, and contract manufacturing. These two companies have dipped their toes in high growth areas.
These companies with strong fundamentals and strategic agility are primed to rebound in 2024. Take a look...